OR5P2: A Potential Drug Target and Biomarker (G120065)
OR5P2: A Potential Drug Target and Biomarker
OR5P2, short for OL5P2R, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is OL5P2 receptor, which is a G protein-coupled receptor (GPCR) that is known for its role in various physiological processes in the body. In recent years, researchers have been interested in studying OR5P2 as a potential drug target and biomarker due to its unique structure and its involvement in several diseases.
The OR5P2 gene was first identified in 2003 by researchers at the University of California, Berkeley. The gene encodes a protein that is composed of 158 amino acids and has a molecular weight of 17.9 kDa. OR5P2 is a member of the GPCR family, which includes over 700 different genes that are involved in various signaling pathways in the body. GPCR proteins are known for their ability to interact with a wide range of molecules, including drugs, which can trigger a variety of physiological responses.
OR5P2 has been shown to play a role in several physiological processes in the body. For example, it is involved in the regulation of the blood pressure, the body's blood flow, and the production of urine. OR5P2 is also involved in the production of insulin, which is a hormone that helps regulate blood sugar levels. Additionally, OR5P2 is involved in the regulation of neural signaling, which is critical for the function of the brain and other nervous tissues.
As a potential drug target, OR5P2 is an attractive target for drug developers because of its unique structure and its involvement in several important physiological processes. OR5P2 is a single transmembrane protein, which means that it is located inside the cell membrane and is in direct contact with the cell's intracellular signaling pathway. This makes it an attractive target for drugs that can modulate its activity and trigger a variety of physiological responses. Additionally, OR5P2 is a good candidate for a drug because it has a high degree of homogeneity, which means that it is similar between different cell types. This makes it easier to understand its biology and to identify potential drug targets.
OR5P2 has also been shown to be involved in several diseases, which makes it an attractive biomarker for diagnostic purposes. For example, OR5P2 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Additionally, OR5P2 has been shown to be involved in the regulation of inflammation, which is a critical factor in the development of many diseases, including heart disease and diabetes.
In conclusion, OR5P2 is a protein that has unique structure and is involved in several important physiological processes in the body. As a potential drug target, OR5P2 is an attractive target for drug developers due to its direct contact with the cell membrane and its involvement in several important physiological processes. Additionally, OR5P2 has been shown to be involved in the development of several diseases, which makes it an attractive biomarker for diagnostic purposes. Further research is needed to fully understand the role of OR5P2 in the body and to develop effective drugs that can modulate its activity.
Protein Name: Olfactory Receptor Family 5 Subfamily P Member 2
Functions: Odorant receptor (Potential). May be involved in taste perception
The "OR5P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR5P2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1 | OR8J3 | OR8K1 | OR8K3 | OR8K5 | OR8S1 | OR8U1 | OR8U3
